SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · David Rodman, an officer of Mineralys Therapeutics, filed a Form 144…

Mineralys Therapeutics, Inc. · 144 filed Apr 17, 2026 at 16:17 ET

At the news

NEUTRALIMPACT 2/10

144 filed Apr 17, 2026 at 16:17 ET

David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 notifying intent to sell 416 shares of common stock, acquired via exercise of employee stock options. This is a routine, small-scale transaction consistent with prior regular sales.

  • Reporting person: David Rodman, Officer
  • Number of shares proposed for sale: 416
  • Nature of shares: Acquired through exercise of employee stock options
  • Method: Broker-assisted cashless exercise

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access